admin – Page 2895 – Get News Story

Electromechanical Actuators in Aircraft Market worth $804.3 Million by 2030, at a CAGR of 6.9%

“Electromechanical Actuators in Aircraft Market”

The Electromechanical Actuators in Aircraft Market Value is projected to be USD 804.3 million by 2030, growing from USD 577.1 million in 2025, at a Compound Annual Growth Rate (CAGR) of 6.9%. during the forecast period.

The report “Electromechanical Actuators in Aircraft Market by Application (Flight Control, Fuel distribution, Cabin Actuation, Door, Landing Gear), Mechanism Type (Linear, Rotary), Motor Torque (<25, 25-100,100-300,>300 Nm), Platform, Region – Global Forecast to 2030” The electromechanical actuators in aircraft market is projected to reach USD 804.3 million by 2030, growing from USD 577.1 million in 2025 at a CAGR of 6.9%. The electromechanical actuators in aircraft market is witnessing strong momentum, fueled by rapid advancements in power electronics, smart sensors, and digital control systems. The growing focus on more electric aircraft (MEA) concepts, which aim to improve energy efficiency and reduce dependency on hydraulic and pneumatic systems, is accelerating the adoption of EMAs. The rising demand for lightweight, maintenance-friendly, and environmentally sustainable solutions encourages innovation in commercial and military aviation. At the same time, evolving defense modernization programs and next-generation aircraft platforms are opening up new opportunities for advanced actuation technologies. Aircraft manufacturers and system integrators increasingly invest in cutting-edge EMA solutions to meet performance, safety, and cost targets. With technology becoming more integrated and platforms more electric, the market is poised for long-term growth. It remains a critical enabler of the aviation industry’s shift toward more innovative, cleaner, and reliable systems.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161099073

Browse 200 market data Tables and 80 Figures spread through 230 Pages and in-depth TOC on “Electromechanical Actuators in Aircraft Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/aircraft-electromechanical-actuators-market-161099073.html

By platform, the narrow-body aircraft segment is projected to account for the largest share of the electromechanical actuators in aircraft market during the forecast period.

The dominance of the narrow-body aircraft segment is underpinned by strong global demand for single-aisle jets, especially across commercial airline fleets. With increasing focus on fleet modernization, airlines are upgrading to newer models, such as the Airbus A320neo and Boeing 737 MAX, which integrate advanced electromechanical actuators (EMAs) for flight control surfaces, landing gear operations, and other critical functions. The adoption of EMAs in narrow-body aircraft is primarily driven by their lower weight, better energy efficiency, and reduced maintenance needs compared to traditional hydraulic systems. Given the high production volumes of narrow-body aircraft and their extensive use in short- and medium-haul routes worldwide, this aircraft continues to attract significant EMA integration. Moreover, the push toward more electric aircraft and increasing passenger traffic in emerging markets further reinforce the segment’s leading market position. Narrow-body platforms are increasingly seen as the foundation for technological upgrades, which makes them central to the EMA market landscape.

By application, the flight control surface segment is projected to account for the largest share during the forecast period.

The flight control surface segment is projected to account for a significant market share, driven by the aviation industry’s shift toward more electric aircraft and the growing need for precise, lightweight, and energy-efficient actuation systems. These actuators play a vital role in managing the aerodynamic behavior of an aircraft, enabling accurate control of ailerons, elevators, rudders, and flaps. As aircraft designs evolve, the demand for advanced EMAs in primary and secondary flight control systems continues to grow, especially in next-generation commercial jets and military platforms. Reduced maintenance needs, enhanced reliability, and better integration with digital flight control architectures have driven the move from hydraulic systems toward electromechanical solutions. With growing emphasis on performance optimization, weight reduction, and environmental efficiency, EMAs for flight control surfaces have become critical to modern aircraft programs.

North America is projected to account for the largest share during the forecast period.

North America remains at the forefront of the Electromechanical Actuators in Aircraft Industry, primarily due to its robust aerospace sector, rich engineering skills base, and drive towards more electric airplane designs. In recent years, there has been a well-documented shift from conventional hydraulic systems toward electromechanical systems, particularly for flight control and landing gear systems. This transformation is fueled by the need to shed weight, increase fuel economy, and make maintenance easier. Industry leaders such as Honeywell, Moog Inc., and Curtiss-Wright are at the forefront of this change, creating more sophisticated and reliable EMA technologies for commercial and defense applications. Regulatory incentives have also played a significant part. The FAA’s emphasis on safety and electrification has driven broader usage of EMA systems throughout aging fleets and new airplanes. The region’s robust supply base, large aircraft programs, and military modernization continue to drive demand for EMS. With increasing focus on testing, certification, and system integration, North America is emerging as a leading center for electromechanical actuator innovation and deployment.

Honeywell International Inc. (US), Curtiss-Wright Corporation (US), Liebherr (Switzerland), and Ametek Inc. (US) are major players in the Electromechanical Actuators in Aircraft Companies. These companies have strong distribution networks across North America, Europe, Asia Pacific, the Middle East, and Rest of the World.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/aircraft-electromechanical-actuators-market-161099073.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Electromechanical Actuators in Aircraft Market worth $804.3 Million by 2030, at a CAGR of 6.9%

AI Voice Generator Market Growth Outlook, Future Scope, Emerging Trends, Technologies, Top Countries Data, Opportunities and Forecast 2030

“IBM (US), NVIDIA (US), OpenAI (US), Meta (US), Microsoft (US), Google (US), AWS (US), Cisco (US), SoundHound (US), Speechify (US), ElevenLabs (US), Synthesia (UK), PlayHT (US), Resemble AI (US), Stability AI (UK), Runway (US).”

AI Voice Generator Market by Technology (Deep Learning, Transformer Models, Generative Adversarial Networks (GANs), Autoencoder, Voice Translation, Voice Cloning, Text to Speech, Virtual Assistants, AI Music Generator) – Global Forecast to 2030

The global AI voice generator market is anticipated to increase from an estimated USD 3.0 billion in 2024 to USD 20.4 billion by 2030, at a compound annual growth rate of 37.1%. The growing demand for AI-based translation and multilingual support services in international markets, the increasing consumption of audio content, and ongoing advancements in AI and ML technologies that enable more precise and effective AI audio generator and speech generator solutions are the main factors propelling market growth.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144271159

By application, voice conversion and cloning to register the second largest market share during the forecast period.

Voice conversion and cloning application will have a significant portion of the AI voice generator market as a result of their versatile abilities in various sectors. These applications provide authentic voice imitation and customization, improving user experiences in customer service, entertainment, and accessibility solutions. Increasing need for voice assistants, immersive gaming, and personalized content is fueling the adoption even more. Improvements in AI algorithms helps to achieve human-like, realistic voice results. Rendering these applications have become more important for companies aiming to interact with users in a more efficient and innovative manner.

By vertical, healthcare & life sciences is poised for the fastest growth rate during the forecast period.

The healthcare and life sciences sector will register for the fastest growth rate in the AI voice generator market due to the increasing use of AI-based tools in patient care and optimize operational processes. AI based virtual assistants for patient engagement and automated transcription services for medical records are changing the way healthcare is provided. The integration of generative AI technologies is being pushed by the need for remote patient monitoring, telehealth services, and precise diagnostics. Furthermore, the increasing demand for fast and successful communication between healthcare professionals and patients, particularly in settings with multiple languages, continues to drive the expansion of AI technologies in this industry over the predicted period.

By region, North America accounts for the largest market during forecast period.

North America is projected to dominate the AI voice generator market in the forecast period because of multiple important reasons. The strong basis for growth in the region is built on its solid technological infrastructure and quick integration of advanced technologies. North America is the base to leading technology firms and AI research centers which indirectly promotes growth and development in the country. Trained workforce and major investments in AI research and development continue to fuel market growth. The growing need for AI audio generator solutions in fields like media & entertainment, healthcare, and BFSI enhances the region’s leading market position.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=144271159

Unique Features in the AI Voice Generator Market

AI voice generators have advanced to a stage where they can mimic human speech patterns, intonations, and emotions with astonishing accuracy. Using deep learning models and neural networks, these tools produce synthetic voices that are nearly indistinguishable from real human voices, enabling immersive experiences in gaming, content creation, and customer support.

One of the standout features of modern AI voice generators is their ability to support multiple languages and dialects. This allows businesses to localize content globally with consistent voice quality, enabling seamless communication across geographic boundaries and enhancing user engagement across diverse linguistic audiences.

AI voice cloning technology allows users to create unique voice avatars or replicate specific voices from a few seconds of recorded audio. This has become particularly popular in branding, entertainment, and accessibility use cases, where personalized audio output enhances authenticity and inclusivity.

Several AI voice solutions now support real-time voice synthesis and voice conversion, enabling live applications such as virtual assistants, AI-powered customer service, and online broadcasting. These tools are capable of converting text to speech on the fly or transforming one voice into another in real-time.

Major Highlights of the AI Voice Generator Market

The AI voice generator market is witnessing strong growth due to increasing adoption across various sectors such as entertainment, eLearning, customer service, gaming, and healthcare. Organizations are leveraging synthetic voices to reduce production costs, enhance accessibility, and offer multilingual voice solutions at scale.

With the surge in usage of smart home devices and virtual assistants like Alexa, Google Assistant, and Siri, the need for natural, responsive AI voices is growing rapidly. This trend is pushing vendors to innovate voice solutions that are more expressive, interactive, and human-like.

AI voice technology is being increasingly integrated into broader generative AI workflows, including video generation, avatars, and conversational AI. This convergence is fueling demand for seamless voice-to-video and text-to-speech pipelines in marketing, content production, and virtual human development.

Businesses are using AI voice generation to create custom voice personas that align with their brand identity. This not only strengthens customer engagement but also allows consistent communication across platforms, especially in digital marketing, IVR systems, and voice commerce.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144271159

Top Companies in the AI Voice Generator Market

Some leading players in the AI voice generator market include IBM (US), NVIDIA (US), OpenAI (US), Meta (US), Microsoft (US), Google (US), AWS (US), Cisco (US), SoundHound (US), Speechify (US), ElevenLabs (US), Synthesia (UK), PlayHT (US), Resemble AI (US), Stability AI (UK), Runway (US). These players have adopted various kinds of organic and inorganic growth strategies, such as new product launches, partnerships and collaborations, and mergers and acquisitions, to expand their presence in the AI voice generator market.

Google

Google has been at the forefront of advancements in AI voice generator landscape, drawing on its deep expertise in artificial intelligence and machine learning. Google has greatly improved user interactions and accessibility with advanced natural language processing and speech recognition technologies, like Google Assistant. The company’s dedication to innovation can be seen in its ongoing creation of AI-powered tools like WaveNet and Tacotron, which produce extremely lifelike speech synthesis. Furthermore, Google’s AI research efforts are centered on enhancing the precision, speed, and adaptability of AI audio generator and AI speech generator technologies, which are utilized in various applications such as customer service automation and content generation. Google’s dedication to excellence establishes them as a front-runner in the AI voice generator industry, propelling progress and establishing benchmarks.

AWS

Amazon Web Services (AWS) is one of the major players in the AI voice generator market, providing a wide range of AI and machine learning options to assist in creating and launching advanced AI audio generator and AI speech generator programs. AWS offers strong features in AI, like Amazon Transcribe, Amazon Polly, and Amazon Lex, for converting speech to text, creating natural-sounding speech from text, and designing conversational interfaces. These services offer high scalability, security, and integration, enabling businesses to utilize generative AI’s potential without requiring significant investments in infrastructure. Moreover, AWS’s ongoing advancements and improvements in AI and ML technologies guarantee that customers can utilize the most recent progressions, promoting faster development timelines and facilitating the development of more organic, effective, and tailored voice solutions.

Microsoft

By utilizing its Azure AI platform and substantial research in machine learning and natural language processing (NLP) Microsoft has been at the forefront of incorporating AI voice generator technologies. The company provides robust solutions for text-to-speech, speech translation and speech recognition serving a range of industries including education, healthcare, and customer service through products like Microsoft Speech Service and Azure Cognitive Services. Microsoft has demonstrated its dedication to innovation through the creation of state-of-the-art models including the neural text-to-speech (TTS) system which generates speech resembling that of a human and the application of generative AI to improve accessibility tools for people with disabilities. Microsoft wants to promote the use of AI voices by working with leaders in the industry and investing continuously in AI research. This will enhance user experiences and operational efficiency in a variety of applications.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ai-voice-generator-market-144271159.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AI Voice Generator Market Growth Outlook, Future Scope, Emerging Trends, Technologies, Top Countries Data, Opportunities and Forecast 2030

$101.5 Million Preliminary Net Revenue for Jan-May 2025 Puts AI Telcom Leader On Track to Meet $340 Million Annual Forecast: IQSTEL, Inc. (Nasdaq: IQST)

Current Performance Trends and Pipeline Visibility, $IQST Expects to Reach a $400 Million Annualized Revenue Run Rate by End of 2025

IQST Delivers Diversified Business with Divisions Focused on Telecommunications, Fintech, Electric Vehicles, Artificial Intelligence and More.

IQST Has Organic Growth, Acquisitions and High-Margin Product Expansion.

New IQST Rebrand Program with Expansion into Fintech, AI and Cybersecurity to Address Challenges Across Multiple Industries.

$101.5 Million in Preliminary Net Revenue for Jan-May 2025, On Track with $340 Million Annual Forecast.

IQST and CYCU Announce the Advancement of Their Strategic Partnership to Serve the Global Cybersecurity Market with AI-Powered Platform.

Global Cybersecurity Market is Expected to Surpass $500 Billion by 2030, Fueled by Rapid Digital Transformation, Cloud Adoption and Escalating Cyber Threats.

IQST Has Definitive Agreement to Acquire 51% of GlobeTopper fintech innovator with operations across America, Europe, and Africa, Effective July 1, 2025.

IQST Shareholders to Receive ASII Common Shares as a Dividend as Part of Nasdaq Uplisting Plan.

IQSTEL, Inc. (Nasdaq: IQST) offers cutting-edge solutions in Telecom, Fintech, Blockchain, Artificial Intelligence (AI), and Cybersecurity. Operating in 21 countries, IQST delivers high-value, high-margin services to its extensive global customer base. IQST projects $340 million in revenue for FY-2025, building on its strong business platform.

IQST has been building a strong business platform with its customers, selling them millions of dollars per month, and by leveraging this trust, the company is now beginning to sell high-tech, high-margin products across its divisions. IQST is strategically positioned to achieve $1 billion in revenue by 2027 through organic growth, acquisitions, and high-margin product expansion.

IQST Reports $101.5 Million in Preliminary Net Revenue for Jan-May 2025, On Track to Meet $340 Million Annual Forecast

On June 24th IQST announced preliminary accounting revenue of $101.5 million for the period January through May 2025, reaffirming the company is on track to meet its full-year revenue forecast of $340 million.

Historically, the second half of the year outperforms the first, and IQST business momentum is now accelerating significantly. IQST reported $23.7 million in net revenue for May alone, with projections to reach $33 million in monthly net revenue by year-end—or earlier—driven by both organic growth and strategic integration. Based on current performance trends and pipeline visibility, IQST expects to reach a $400 million annualized revenue run rate by the end of 2025.

A key catalyst in this growth trajectory is the upcoming integration of GlobeTopper, a fintech platform expected to join the IQST family within the next week. GlobeTopper is anticipated to contribute millions of dollars in revenue and will also add positive EBITDA, further strengthening the company’s fintech division and bottom line.

The IQST recent uplisting to NASDAQ has been met with strong market interest, reflected in millions of dollars in daily trading volume. Management views this as a strong validation of IQSTEL’s long-term value proposition. The IQST vision to become a $1 billion revenue company by 2027 is becoming increasingly tangible.

IQST – IQSTEL and Cycurion (CYCU) Unveil Plans for AI-Powered Next-Generation Cybersecurity Platform, Targeting the Global Telecom Industry

On June 18th IQSTEL Inc. (NASDAQ: IQST), a leading provider of high-tech telecommunications and technology solutions, and Cycurion Inc. (NASDAQ: CYCU), an innovative cybersecurity company, are pleased to announce the advancement of their strategic partnership, originally signed a few months ago.

Since entering into the agreement, both companies have worked closely to define and design customized cybersecurity solutions for the evolving needs of the global telecom industry. The IQST – CYCU collaboration is now entering an execution phase, focused on product rollout and market deployment.

Six Pillars of Collaboration

1. Cybersecurity for Telecom Carrier Infrastructure

IQST and CYCU are developing advanced cybersecurity solutions to protect critical telecom carrier operations, including:

Destination rates

Routing engine rules

Billing and accounting systems

CRM and ERP platforms

Sensitive customer and vendor financial information

These protections are designed to fortify telecom networks against breaches and operational risks.

2. White-Label Cybersecurity Services for Telecom Operators

IQST and CYCU are launching “Cyber Shield,” a white-label cybersecurity platform that major telecom carriers can offer to their own customers, including:

Large enterprises

Medium-sized businesses

Individual consumers

This solution enables telecom operators to add high-margin cybersecurity services to their portfolio—strengthening customer retention and unlocking new revenue streams.

3. AI-Driven Operational Optimization for Cycurion

CYCU is exploring integration of IQSTEL Intelligence, a proprietary AI platform, to:

Optimize internal operations

Reduce costs

Accelerate execution of high-value contracts currently under negotiation

4. AI-Powered Next-Generation Cybersecurity Platform

IQST and CYCU are collaborating to develop an AI-Powered Next-Generation Cybersecurity Platform, with the initiative led by IQSTEL’s Intelligence Division—the company’s dedicated unit for advanced AI research and development.

This new platform is designed to:

Increase predictive protection, enabling the identification and neutralization of threats before they materialize.

Enhance adaptive response, allowing intelligent, real-time countermeasures that evolve with new attack patterns.

By combining CYCU deep cybersecurity expertise with IQST proprietary AI technologies, the companies aim to deliver a cutting-edge, proactive defense system built specifically for telecom operators and large-scale digital ecosystems. This initiative positions IQST and CYCU as global leaders in AI-enhanced telecom cybersecurity.

5. Time-to-Market in H2 2025

IQST and CYCU are actively planning a commercial launch in the second half of 2025. Joint teams are aligning on product development, packaging, and go-to-market strategies to ensure a coordinated, global rollout.

6. Cybersecurity Market Size and Global Opportunity

According to industry forecasts, the global cybersecurity market is expected to surpass $500 billion by 2030, fueled by rapid digital transformation, cloud adoption, and escalating cyber threats.

The telecom sector, responsible for massive data flows and sensitive information, urgently requires robust digital defense. IQST and CYCU are uniquely positioned to serve this demand, combining AI and cybersecurity into a scalable, telecom-specific solution.

With a presence in more than 20 countries across 4 continents and established commercial relationships with over 600 telecom operators, IQST provides an ideal platform to deliver world-class cybersecurity solutions at global scale.

IQST Rapid Global Fintech Expansion with GlobeTopper Acquisition — Fast-Tracking $1 Billion Growth Plan

On May 29th IQST announced the execution of a definitive agreement to acquire 51% of GlobeTopper (GlobeTopper.com) — a dynamic fintech innovator with operations across America, Europe, and Africa. The transaction becomes effective July 1, 2025. GlobeTopper’s strong market positioning is evident in its current standalone performance — planning to generate over $65 million in profitable revenue in 2025 alone. Its financial outlook for the next three years reflects steady growth and operational momentum.

The IQST goal is to take GlobeTopper’s innovative fintech products and services and scale them globally through IQSTEL’s powerful commercial platform — which already reaches over 600 of the largest telecom operators around the world. In parallel, GlobeTopper’s existing client base — including prominent multinational brands — opens the door for IQST to expand its reach into new sectors, allowing deeper penetration into the enterprise and global brand markets.

Together, IQST and GlobeTopper plan lead the next wave of convergence between fintech and telecommunications in high-value markets across Africa, Europe, and the Americas. As part of the transaction, Craig Span will continue in his role as CEO of GlobeTopper, ensuring leadership continuity and seamless integration into the IQST Fintech Division.

GlobeTopper will collaborate with GlobalMoneyOne.com, co-developing a 3-year business plan to position itself as a top-tier player in the global fintech ecosystem. The deal puts IQST firmly on track to reach a $400 million revenue run rate and achieve a targeted 80% telecom / 20% tech revenue mix by the end of this year. This acquisition strengthens the IQST position as a high-margin, tech-focused growth platform, advancing its $1 billion revenue goal by 2027. Additionally, IQST plans to invest up to $1.2 million over the next 2 yearsto accelerate GlobeTopper’s growth and product roadmap.

For more information on $IQST visit: www.iQSTEL.com

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Media Contact
Company Name: IQSTEL Inc.
Contact Person: Leandro Jose Iglesias, President and CEO
Email: Send Email
Phone: +1 954-951-8191
Address:300 Aragon Avenue Suite 375
City: Coral Gables
State: Florida 33134
Country: United States
Website: www.iQSTEL.com

From Vision to Action: CIIE Empowers Global Development Through Inclusive Cooperation

Amid growing global uncertainty and anti-globalization sentiment, the China International Import Expo (CIIE) remains a vital platform for openness and cooperation. A UN-hosted event in Geneva on June 25, themed “Working Together to Implement the UN 2030 Agenda—How China International Import Expo Helps,” showcased its role in fostering inclusive growth.

At the event, representatives from dōTERRA, and Warmpaca shared how the CIIE has opened doors for them in the Chinese market. Since 2018, dōTERRA has partnered with Guizhou through the CIIE, using innovation to boost the value of traditional Chinese plants and raise local farmers’ incomes. Warmpaca made its breakthrough at the inaugural CIIE. By partnering with over 1,000 families to produce handmade alpaca wool goods, it has successfully expanded into both the Chinese and global markets—creating jobs and empowering local communities along the way.

As the expo approaches, preparations have entered a new and dynamic phase. On May 22, a dedicated matchmaking event was held in Chongqing, bringing together nearly 40 exhibitors and over 110 local buyers. The event laid a solid foundation for deeper cooperation in the lead-up to the CIIE. To date, an exhibition area of over 280,000 square meters has been booked for this year’s CIIE. This year, the exhibition layout has been further optimized to spotlight innovation, advanced technologies, and cutting-edge services.

Building on this momentum, the upcoming China-Central Asia Summit will boost exchanges and cooperation. As regular participants in the CIIE, Central Asian countries have continued to strengthen ties with China through this key platform. For instance, at the seventh CIIE, Kazakh businesses took part in an unprecedented scale, presenting a broader range of high-quality products to the Chinese market.

The upcoming eighth CIIE is set to attract a broader spectrum of exhibitors, professional buyers and visitors across sectors. Meanwhile, the HQF will serve as a key venue for dialogue on open economies and inclusive globalization.

For more information, visit CIIE official website: https://www.ciie.org/zbh/en/

Media Contact
Company Name: China International Import Expo
Contact Person: CUI Yan
Email: Send Email
Country: China
Website: https://www.ciie.org/zbh/en

VSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare Market

With Backing from NASA, the U.S. Government, and a $328M Stroke Rehab Opportunity on Deck, VSee Is Quietly Becoming a Major Force in Next-Gen Healthcare

Imagine a world where stroke recovery happens from the comfort of home. A world where AI-powered nursing robots reduce hospital costs, and maternal care reaches the most remote corners of the world with just a mobile signal. That’s not a futuristic dream—it’s the reality VSee Health (Nasdaq: VSEE) is building today.

Already trusted by NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and even the entire nation of Qatar, VSEE is quietly positioning itself as a backbone for digital healthcare infrastructure globally.

And now, it’s been chosen to support a Phase 3 NIH-funded clinical study on stroke rehabilitation, unlocking a $328 million global market and sending a strong signal to investors: VSEE is a telehealth leader with real-world traction, high-value contracts, and breakout potential.

$328M Stroke Rehab Market Now in VSee’s Sights

On June 23, VSee announced it has been selected to power a UCLA-led, NIH-funded Phase 3 clinical trial for stroke recovery telerehabilitation. The study will include 202 patients across 29 hospitals, testing whether home-based, gamified rehabilitation using VSee’s platform can significantly improve arm mobility in stroke survivors—while slashing costs tied to travel, caregivers, and hospital readmissions.

“This is the kind of national, evidence-backed validation investors dream about,” said one industry analyst.

If successful, the study could trigger Medicare and private payer reimbursements, opening doors to widespread commercialization in the stroke recovery market—and beyond. VSee’s telerehab tools could soon be applied to other high-cost areas like spinal cord injuries, multiple sclerosis, and traumatic brain injuries.

From the Philippines to U.S. Hospitals: Scaling Globally with AI

VSEE isn’t just growing—it’s making impact globally. On May 16, the company launched Project MAMA in the remote Philippines, using AI chatbots, portable diagnostic tools, and tele-OB-GYN services to combat maternal mortality in underserved areas. The pilot went live in just four days, demonstrating how fast VSee can deploy critical healthcare infrastructure.

Back in the U.S., the company recently unveiled a Telenursing Robotics platform aimed at cutting hospital nursing costs by 3–5%, addressing a $300 billion labor challenge in American healthcare. The solution automates routine nursing tasks, improving patient throughput while relieving overwhelmed hospital staff.

Modular, No-Code, “Lego-Like” AI Platform That Scales Fast

VSee’s biggest edge? Its modular, no-code/low-code platform that allows hospitals and governments to build customized digital health ecosystems without hiring a single engineer. Described as “Lego-like digital health building blocks,” VSee’s technology integrates with major EHR systems (like Oracle Cerner), supports multilingual communication in 240+ languages (via LanguageLine), and powers over 1.5 million HIPAA-compliant video visits per month.

This unmatched flexibility is why VSee keeps winning big:

$2M hospital contract for neurocritical care robotics.
$560K deal with a major oncology network.
$444K government mental health platform contract.
$6M+ government telehealth deployment agreement—just in its first year.
EHR integration with DaVita’s top kidney care provider to improve telehealth call success rates by 88%.

Telepresence Robots, Unified Health Records & More

In addition to NIH trials and hospital contracts, VSee is collaborating with Ava Robotics to bring intelligent telepresence robots to ICUs, allowing doctors to remotely round on patients with real-time video and data.

Meanwhile, its partnership with AbundaBox launched AbundaLife™, a revolutionary platform to unify patient medical records into one secure profile—solving the $30B+ fragmentation problem in healthcare data.

Built for the Future of Healthcare

Whether it’s autonomous robotics, remote maternal care, gamified rehab, or multilingual telehealth, VSee isn’t reacting to the digital health future—it’s building it. With a platform already trusted by the U.S. government, NASA, and a growing list of major healthcare providers, VSee is now positioned to lead in:

Stroke recovery
Critical care
Rural maternal health
Hospital workforce automation
Chronic disease management

Investor Takeaway: A Pure-Play AI Telehealth Growth Story

VSee Health ($VSEE) stands at the crossroads of AI, telehealth, robotics, and healthcare accessibility—all major investment themes for 2025 and beyond. With clinical validation from the NIH, a growing roster of contracts and partnerships, and a platform that delivers at scale, VSee is more than a telehealth company—it’s a digital health infrastructure play.

And with the global digital health market projected to hit $787 billion, VSee’s current valuation could represent just the beginning.

Website: www.vseehealth.com

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Media Contact
Company Name: Vsee Health, Inc.
Contact Person: Anne Chang
Email: Send Email
Phone: 626-513-1824
Address:One Gateway Center Suite 507 300 Washington St.
City: Newton
State: Massachusetts
Country: United States
Website: www.vseehealth.com

Crohn’s Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | AstraZeneca, Immunic, Suzhou Connect Biopharmaceuticals, Pfizer

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Crohn’s Disease pipeline constitutes 40+ key companies continuously working towards developing 50+ Crohn’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Crohn’s Disease Pipeline Insight, 2025“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Crohn’s Disease Market.

Crohn’s disease is a chronic inflammatory condition that primarily affects the gastrointestinal tract, causing inflammation anywhere from the mouth to the anus, but most commonly in the small intestine and the beginning of the large intestine (colon). It belongs to a group of conditions known as inflammatory bowel diseases (IBD).

Some of the key takeaways from the Crohn’s Disease Pipeline Report:

Companies across the globe are diligently working toward developing novel Crohn’s Disease treatment therapies with a considerable amount of success over the years.
Crohn’s Disease companies working in the treatment market are Morphic Therapeutic, Orchard Therapeutics, Thetis Pharmaceuticals, AstraZeneca, Immunic, Suzhou Connect Biopharmaceuticals, Pfizer, Bristol-Myers Squibb, Eisai Inc, Janssen Pharmaceutical, Eli Lilly and Company, Gilead Sciences, RedHill Biopharma, Celgene Corporation, AstraZeneca, and others, are developing therapies for the Crohn’s Disease treatment

Emerging Crohn’s Disease therapies in the different phases of clinical trials are- MORF 057, OTL-104, TP-317, AZD 7798, IMU 856, CBP-307, PF-06651600, Deucravacitinib, E6011, Guselkumab, Mirikizumab, Filgotinib, RHB-104, Ozanimod, Brazikumab, and others are expected to have a significant impact on the Crohn’s Disease market in the coming years.
In March 2025, Celltrion announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), after receiving FDA approval in December 2024. STEQEYMA is authorized for the same indications as STELARA, ensuring reliable treatment options for both patients and healthcare providers.
In March 2025, Johnson & Johnson announced that the FDA has approved TREMFYA® (guselkumab), making it the first and only IL-23 inhibitor offering both subcutaneous (SC) and intravenous (IV) induction options for adults with moderately to severely active Crohn’s disease (CD), a chronic inflammatory condition affecting the gastrointestinal tract.
In February 2025, Eli Lilly shared findings from the VIVID-2 open-label extension study at the Crohn’s and Colitis Congress (CCC), revealing that most patients with moderately-to-severely active Crohn’s disease treated continuously with OMVOH for two years achieved sustained clinical and endoscopic outcomes, including 43.8% of patients who had previously failed biologic therapies.
In January 2025, The FDA approved OMVOH (mirikizumab) for Crohn’s disease, reinforcing the role of IL-23 inhibitors. Demonstrating robust long-term effectiveness, OMVOH is also under investigation for use in pediatric patients, potentially fulfilling a critical unmet need in this group.

Crohn’s Disease Overview

Crohn’s Disease is a chronic inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, most commonly affecting the small intestine and the beginning of the colon. It can lead to symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. The exact cause is unknown but is believed to involve an abnormal immune response, genetics, and environmental factors. Crohn’s can affect any part of the gastrointestinal tract and may lead to complications like strictures, fistulas, or bowel obstruction. While there is no cure, treatments including medications, dietary changes, and sometimes surgery can help manage symptoms and inflammation.

Get a Free Sample PDF Report to know more about Crohn’s Disease Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/crohns-disease-cd-pipeline-insight

Emerging Crohn’s Disease Drugs Under Different Phases of Clinical Development Include:

MORF 057: Morphic Therapeutic
OTL-104: Orchard Therapeutics
TP-317: Thetis Pharmaceuticals
AZD 7798: AstraZeneca
IMU 856: Immunic
CBP-307: Suzhou Connect Biopharmaceuticals
PF-06651600: Pfizer
Deucravacitinib: Bristol-Myers Squibb
E6011: Eisai Inc
Guselkumab: Janssen Pharmaceutical
Mirikizumab: Eli Lilly and Company
Filgotinib: Gilead Sciences
RHB-104: RedHill Biopharma
Ozanimod: Celgene Corporation
Brazikumab: AstraZeneca

Crohn’s Disease Route of Administration

Crohn’s Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Parenteral
Intravenous
Subcutaneous
Topical

Crohn’s Disease Molecule Type

Crohn’s Disease Products have been categorized under various Molecule types, such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

Crohn’s Disease Pipeline Therapeutics Assessment

Crohn’s Disease Assessment by Product Type
Crohn’s Disease By Stage and Product Type
Crohn’s Disease Assessment by Route of Administration
Crohn’s Disease By Stage and Route of Administration
Crohn’s Disease Assessment by Molecule Type
Crohn’s Disease by Stage and Molecule Type

DelveInsight’s Crohn’s Disease Report covers around 50+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Crohn’s Disease product details are provided in the report. Download the Crohn’s Disease pipeline report to learn more about the emerging Crohn’s Disease therapies

Some of the key companies in the Crohn’s Disease Therapeutics Market include:

Key companies developing therapies for Crohn’s Disease are – Janssen, RedHill Biopharma, Amgen, Pfizer, Prometheus Biosciences, AgomAb Therapeutics, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Mesoblast, Alfasigma, Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem Inc., Stero Biotechs, Reistone Biopharma Company Limited, Qu Biologics, Pfizer, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceuticals, Soligenix, Immunic, Pfizer, Atlantic Healthcare, 4D Pharma, and others.

Crohn’s Disease Pipeline Analysis:

The Crohn’s Disease pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Crohn’s Disease with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Crohn’s Disease Treatment.
Crohn’s Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Crohn’s Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Crohn’s Disease market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Crohn’s Disease drugs and therapies

Crohn’s Disease Pipeline Market Drivers

High prevalence of Crohn’s Disease, increase in Drug Development for Crohn’s treatment, change in lifestyle patterns are some of the important factors that are fueling the Crohn’s Disease Market.

Crohn’s Disease Pipeline Market Barriers

However, lack of early diagnosis of the disease, high cost associated with the treatment and other factors are creating obstacles in the Crohn’s Disease Market growth.

Scope of Crohn’s Disease Pipeline Drug Insight

Coverage: Global
Key Crohn’s Disease Companies: Morphic Therapeutic, Orchard Therapeutics, Thetis Pharmaceuticals, AstraZeneca, Immunic, Suzhou Connect Biopharmaceuticals, Pfizer, Bristol-Myers Squibb, Eisai Inc, Janssen Pharmaceutical, Eli Lilly and Company, Gilead Sciences, RedHill Biopharma, Celgene Corporation, AstraZeneca, and others
Key Crohn’s Disease Therapies: MORF 057, OTL-104, TP-317, AZD 7798, IMU 856, CBP-307, PF-06651600, Deucravacitinib, E6011, Guselkumab, Mirikizumab, Filgotinib, RHB-104, Ozanimod, Brazikumab, and others
Crohn’s Disease Therapeutic Assessment: Crohn’s Disease current marketed and Crohn’s Disease emerging therapies
Crohn’s Disease Market Dynamics: Crohn’s Disease market drivers and Crohn’s Disease market barriers

Request for Sample PDF Report for Crohn’s Disease Pipeline Assessment and clinical trials

Table of Contents

1. Crohn’s Disease Report Introduction

2. Crohn’s Disease Executive Summary

3. Crohn’s Disease Overview

4. Crohn’s Disease- Analytical Perspective In-depth Commercial Assessment

5. Crohn’s Disease Pipeline Therapeutics

6. Crohn’s Disease Late Stage Products (Phase II/III)

7. Crohn’s Disease Mid Stage Products (Phase II)

8. Crohn’s Disease Early Stage Products (Phase I)

9. Crohn’s Disease Preclinical Stage Products

10. Crohn’s Disease Therapeutics Assessment

11. Crohn’s Disease Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Crohn’s Disease Key Companies

14. Crohn’s Disease Key Products

15. Crohn’s Disease Unmet Needs

16 . Crohn’s Disease Market Drivers and Barriers

17. Crohn’s Disease Future Perspectives and Conclusion

18. Crohn’s Disease Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Crohn’s Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | AstraZeneca, Immunic, Suzhou Connect Biopharmaceuticals, Pfizer

State Grid Zhejiang Electric Power promotes energy conservation in public buildings by taking international standards as the starting point

On June 17, IEEE IAS (Institute of Electrical and Electronics Engineers for Industrial and Commercial Applications) officially released the technical standard “Guidelines for Energy-saving and Lightweight Transformation and Operation and Maintenance of Electrical Facilities in Existing Industrial and Commercial Buildings”, which was led by State Grid Zhejiang Electric Power. The standard will provide clear technical specifications and implementation paths for lightweight and energy-efficient renovations of industrial and commercial buildings worldwide.

Picture above: IEEE International standard

Public buildings are a key area of building energy consumption. According to the 2023 China Building Energy Consumption and Carbon Emissions Research Report, about 15 billion square meters of public buildings in China, accounting for only 21% of all building area, consume 42% of the building’s operating energy, reaching 480 million tons of standard coal equivalent. Among them, the energy consumption level of urban commercial buildings is 10 to 15 times that of ordinary residential buildings. Reducing their high energy consumption has become an important part of achieving the “dual carbon” goals.

In response to the “pain points” of traditional renovation plans, such as significant structural damage and high costs, State Grid Zhejiang Electric Power Co., Ltd. has proposed a lightweight green, smart and low-carbon building renovation solution featuring “cloud-network integration, system integration, strategy symbiosis, multi-terminal linkage and holistic perception”. This solution does not damage the structural decoration, does not affect normal office work, does not modify the original electrical facilities, the renovation cost is as low as about 15 yuan per square meter, and the renovation period for 20,000 square meters of buildings is within two weeks. The average energy-saving rate of the renovated buildings is over 20%, and the load regulation capacity is over 30%. This “small changes, big results” model quickly gained the attention of building owners, operators and power suppliers around the world, and was also recognized by the IEEE Standards Review Committee.

Picture above: Low Carbon Building Digital Monitoring Center

Under the impetus of State Grid Zhejiang Electric Power Co., LTD., the technical essence and normative requirements distilled from this successful practice have eventually been condensed into international standards. The standard elaborates on how to reduce lighting, implement flexible control of air conditioning temperature, and lower the power consumption of large electrical equipment, etc. It clarifies the overall technical requirements, software technical requirements, energy-saving control requirements, hardware technical requirements, etc., providing practical guidance for global building energy-saving renovations.

Mr. Rui, the executive director of the Standards Review Committee of the Institute of Electrical and Electronics Engineers, highly praised the standard, considering it the world’s first standardized guidance document in the field of building electrical energy conservation, which is of great significance for improving global energy efficiency and promoting sustainable development.

(By Luo Zhen and Qian Ying)

Media Contact
Company Name: State Grid Zhejiang Electric Power Company
Contact Person: Mr. Luo
Email: Send Email
Country: China
Website: https://www.zj.sgcc.com.cn

Strategic Partnership Powers the Future of RFID Packaging: Nosco + Avery Dennison

RFID is no longer optional, it’s essential. Nosco is taking it to the next level through a strategic partnership with industry leader Avery Dennison. Together, they are unlocking new potential in RFID-enabled packaging, giving healthcare and consumer packaged goods (CPG) brands the tools they need to safeguard patients, fight counterfeiting, optimize inventory control and improve supply chain visibility.

This collaboration brings together Nosco’s decades of expertise in high-quality, compliance driven packaging with Avery Dennison’s leadership in RFID technology, ensuring their customers receive end-to-end, future ready solutions from a single trusted source.

Both Nosco and Avery Dennison see this partnership as a powerful example of how smart packaging can scale across industries. By combining Nosco’s precision and packaging expertise with Avery Dennison’s advanced RFID technology, the two companies are working to transform how brands engage with their products and customers. “Working together to grow RFID adoption is an exciting step forward in bridging the physical and the digital,” said DJ Lee, Director of Inlay Sales for Avery Dennison North America.

Why This Partnership Matters

From medications and medical devices to premium consumer products, demand is growing for smart packaging that does more than contain a product; it connects, protects and performs. Nosco and Avery Dennison are meeting that need head-on with solutions that are:

– Retail compliant and focused on the future

– Designed to enhance safety, traceability and trust

– Scalable for established brands and emerging ones alike

– Backed by advanced RFID inlay technology and verified label production

“We see the partnership between Nosco and Avery Dennison as a model for how smart packaging can scale across industries; combining precision, speed and trust,” said Lee. “It’s not just about adding RFID; it’s about transforming how brands engage with their products and customers.”

Innovation Through Collaboration

“At Nosco, we believe printed packaging should deliver more than a product; it should deliver value,” said Craig Curran, Nosco President. “This partnership with Avery Dennison strengthens our ability to support brands at every stage of RFID adoption, with a shared commitment to driving innovation and making smart packaging smarter.”

Step into the future with RFID packaging. Click here to learn more.

ABOUT NOSCO

Nosco is a full-service packaging solutions provider serving over 400+ customers in the healthcare space. With more than 115 years of experience, Nosco brings together business resources and technical expertise to better understand packaging challenges and deliver customized solutions. The company focuses on service to help continuously improve efficiencies related to supply chain, cycle times, lean initiatives and product launches.

Nosco is a subsidiary of Holden Industries, Inc., and is 100% employee owned. The company employs 650+ employee owners, and specializes in printed packaging for the pharmaceutical and CPG markets with four core product lines: cartons, labels, inserts and flexible packaging.

ABOUT AVERY DENNISON

Avery Dennison is a global materials science and digital identification solutions company. They are Making Possible products and resources that optimize labor and supply chain efficiency, reduce waste, and advance sustainability. They design and develop labeling and functional materials, RFID inlays and tags, software applications, and offerings that carry information that improves the customer experience.

Media Contact
Company Name: Nosco
Contact Person: Ashley Diehl
Email: Send Email
Country: United States
Website: https://www.nosco.com/rfid?utm_source=pressreleases&utm_medium=referral&utm_campaign=averydennisonpartnership20250603

Hanley Investment Group Arranges Sale-Leaseback of Single-Tenant Dairy Queen in South Texas at Record-Low Cap Rate

ALICE, Texas – Hanley Investment Group, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that the firm arranged the sale of a single-tenant net-leased property occupied by a Dairy Queen Drive-Thru in Alice, Texas. The sale price could not be disclosed. The sale achieved a 5.98% cap rate, a record-low cap rate for the sale of a single-tenant Dairy Queen in Texas in 2025.

Hanley Investment Group’s Vice President Garrett Wood represented the seller, R&L Lozano Leasing, LTD (dba F&P Development) — the real estate development arm of the F&P Group — in association with Priority CRE, LLC DBA Hanley Investment Group. F&P Development is affiliated with F&P Brands, the group’s management company that operates 34 Dairy Queen restaurants and four Schlotzsky’s/Cinnabon units across South Texas and the Corpus Christi area. The transaction was coordinated closely with David Lozano of F&P Development, who managed the process on behalf of the ownership group and worked alongside Hanley throughout the deal’s execution, including structuring, diligence, and closing. The buyer, Susan Caratan 2011 Trust, a private investor based in California, was represented by David Bynum of Bynum, Inc.

“This transaction represents the strongest Dairy Queen cap rate in Texas for 2025, according to CoStar data,” said Wood. “We successfully represented a 30+ unit Dairy Queen franchisee in structuring a new 20-year absolute triple-net sale-leaseback and advised the seller on marketable terms for the new lease agreement. We then secured a 1031 exchange buyer from California and satisfied the seller’s objectives, closing within 45 days from the beginning of escrow.”

F&P Brands’ proven operational strength — with over 35 years of franchise experience and a dedicated leadership team — has established the F&P Group as a market leader in the region. Their portfolio performance and long-term commitment to the communities they serve continue to attract investor confidence.

Wood added, “Selling at an aggressive, sub-6% cap rate in a tertiary market with franchisee credit underscores the continued demand for high-quality, net-leased retail assets. In particular, net-leased assets that have a strong guarantor behind the lease, as was the case in this transaction, are highly sought after. This was also a high-performing Dairy Queen location based on sales data, with a healthy rent-to-sales ratio.”

Wood also noted that “Well-capitalized buyers are shaping the retail investment landscape, aggressively pursuing acquisitions with all-cash offers. While interest rates remain a factor, they are less of a deterrent for serious investors.’

The 2,608-square-foot freestanding fast-food restaurant, built in 1983 and renovated in 2015, is equipped with a drive-thru and leased to Dairy Queen. Situated on a 0.61-acre parcel at 1179 E. Main Street, the property benefits from a bustling commercial corridor providing traffic counts of approximately 20,000 vehicles per day. The location is conveniently near the city’s largest employers, including Dixie Iron Works, Forbes Energy, Christus Spohn Hospital, and several local schools.

According to Wood, the new 20-year absolute triple-net initial lease term includes four five-year options and 2.0% annual rent increases every five years, guaranteed by the parent company of the franchisee. This particular Dairy Queen location is a 30+-year-old establishment with above-average sales volume, demonstrating the tenant’s long-standing success.

The Alice, Texas, market continues to show positive trends, with the number of residents within a three-mile radius growing by 12.8% from 2020 to 2024, supporting the long-term viability of the investment.

“The single-tenant net-leased market has nearly doubled in inventory since 2021, but transaction volume has dwindled,” Wood noted. “Investors are sharpening their focus on credit quality — especially in the food-service sector, where rising labor and input costs continue to squeeze margins. This deal highlights the enduring value of strong tenant credit and well-structured leases.

“Texas offers a unique combination of economic stability, population growth, and a favorable business climate, making it an ideal location for retail investment,” highlighted Wood. “The state’s diverse markets, strong infrastructure, and absence of state income taxes provide investors with numerous opportunities for long-term success.”

Over the past 48 months, Hanley Investment Group has facilitated the sale of $534 million worth of retail properties in the Texas market, including the recent sale of a single-tenant 7-Eleven convenience store in McAllen, South Texas, in association with ParaSell, Inc., to a northern California-based all-cash buyer.

Wood, a native Texan with roots tracing back seven generations, has a deep understanding of the state’s diverse market landscape. He assists clients nationwide in buying and selling retail properties in Texas. Garrett’s successful 10-year career in retail investment sales is attributed to his “Boots on the Ground” work ethic and capital connections on the West Coast. Based in the Austin metro area, he leads Hanley Investment Group’s Texas office.

About F&P Group

F&P Group is a family-owned enterprise consisting of F&P Development, which oversees real estate strategy and development, and F&P Brands, which manages operations for 34 Dairy Queen restaurants and four Schlotzsky’s/Cinnabon units across South Texas and the Corpus Christi area. The group’s integrated structure is further supported by F&P Media, their in-house media team, which leads local brand engagement, storytelling, and digital strategy. Known for its commitment to operational excellence, community impact, and smart growth, the F&P Group represents a vertically integrated platform focused on long-term value and brand stewardship. To learn more, visit www.foodandpeople.com.

About Hanley Investment Group

Celebrating 20 years, Hanley Investment Group Real Estate Advisors is a real estate brokerage and advisory services company with an over $11.7 billion transaction track record that specializes in the sale of retail properties nationwide. Our expertise, proven track record, and unwavering dedication to putting clients’ needs first set us apart in the industry. Hanley Investment Group creates value by delivering exceptional results through the use of property-specific marketing strategies, cutting-edge technology, and local market knowledge. Our nationwide relationships with investors, developers, institutions, franchisees, brokers, and 1031 exchange buyers are unparalleled in the industry, translating into maximum exposure and pricing for each property. With unmatched service, Hanley Investment Group has redefined the experience of selling retail investment properties. For more information, visit www.hanleyinvestment.com.

Media Contact
Company Name: Hanley Investment Group Real Estate Advisors
Contact Person: Garrett Wood, Vice President
Email: Send Email
Phone: 512.712.3657
Address:3500 East Coast Highway, Suite 100
City: Corona del Mar
State: California
Country: United States
Website: https://hanleyinvestmentgroup.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hanley Investment Group Arranges Sale-Leaseback of Single-Tenant Dairy Queen in South Texas at Record-Low Cap Rate

Beeline Holdings (NASDAQ: BLNE) Introduces Stablecoin-Driven Next-Gen Home Mortgage – More Stocks Inside

Beeline Holdings, Inc. (NASDAQ: BLNE), a pioneering mortgage fintech company, recently announcing the successful closing of its first-ever fractional equity home sale leveraging a stablecoin-based transaction model. This innovative approach offers a compelling alternative to traditional mortgages by removing interest rate dependencies and enabling faster, blockchain-backed homeownership solutions. Press Release dated June 25, 2025

The transaction marks the first in a series of five to ten beta deals scheduled over the coming weeks ahead of a national rollout set for early August 2025. Beeline’s model combines AI-powered underwriting with a digital title platform, allowing for seamless property transactions with more financial flexibility. See 8k

As it accelerates toward national scale, Beeline Holdings, Inc. (NASDAQ: BLNE) joins a dynamic group of public companies under $5—including QuantumScape Corp. (NYSE: QS), Urgent.ly Inc. (NASDAQ: ULY), Peraso Inc. (NASDAQ: PRSO), Health In Tech Inc. (NASDAQ: HIT), and Synergy CHC Corp. “Focusfactor” (NASDAQ: SNYR)—all positioned to lead the next wave of market-defining disruption across sectors like fintech, clean energy, AI infrastructure, and consumer health.

“This innovation redefines what it means to own a home,” said a company spokesperson. “By utilizing blockchain and stablecoins, we’re making the process faster, more secure, and more accessible.”

Headquartered in Providence, Rhode Island, Beeline is transforming the mortgage landscape with its AI-driven digital lending platform, empowering individuals to achieve greater financial freedom through property equity—not debt.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Beeline Holdings (NASDAQ: BLNE) Introduces Stablecoin-Driven Next-Gen Home Mortgage – More Stocks Inside